Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124981013 | 12498101 | 3 | F | 20160719 | 20160626 | 20160729 | EXP | GB-MHRA-EYC 00140947 | GB-MYLANLABS-2016M1025174 | MYLAN | 0.00 | Y | 0.00000 | 20160729 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124981013 | 12498101 | 1 | PS | IBANDRONATE | IBANDRONATE SODIUM | 1 | Oral | UNK | 202671 | ||||||||||
| 124981013 | 12498101 | 2 | SS | ZOLEDRONIC ACID | ZOLEDRONIC ACID | 1 | Intravenous (not otherwise specified) | 4 MG, UNK | 0 | 4 | MG | ||||||||
| 124981013 | 12498101 | 3 | SS | DISODIUM PAMIDRONATE | PAMIDRONATE DISODIUM | 1 | Intravenous (not otherwise specified) | 90 MG, UNK | 0 | 90 | MG | ||||||||
| 124981013 | 12498101 | 4 | SS | XGEVA | DENOSUMAB | 1 | Subcutaneous | 120 MG, UNK (1.7ML) | N | U | 0 | 120 | MG | ||||||
| 124981013 | 12498101 | 5 | C | CAPECITABINE. | CAPECITABINE | 1 | UNK | U | 0 | ||||||||||
| 124981013 | 12498101 | 6 | C | MORPHINE SULPHATE | MORPHINE SULFATE | 1 | UNK | U | 0 | ||||||||||
| 124981013 | 12498101 | 7 | C | PREGABALIN. | PREGABALIN | 1 | UNK | U | 0 | ||||||||||
| 124981013 | 12498101 | 8 | C | TAMOXIFEN | TAMOXIFEN | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124981013 | 12498101 | 1 | Breast cancer metastatic |
| 124981013 | 12498101 | 2 | Bone disorder |
| 124981013 | 12498101 | 3 | Breast cancer metastatic |
| 124981013 | 12498101 | 4 | Prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124981013 | 12498101 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124981013 | 12498101 | Osteonecrosis of jaw | |
| 124981013 | 12498101 | Tooth abscess |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124981013 | 12498101 | 1 | 20120808 | 201310 | 0 | |
| 124981013 | 12498101 | 2 | 20140402 | 20141210 | 0 | |
| 124981013 | 12498101 | 3 | 201310 | 20140305 | 0 | |
| 124981013 | 12498101 | 4 | 20150114 | 20160428 | 0 |